Laura Capolongo

688 total citations
34 papers, 599 citations indexed

About

Laura Capolongo is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Laura Capolongo has authored 34 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Organic Chemistry. Recurrent topics in Laura Capolongo's work include Cancer therapeutics and mechanisms (16 papers), Synthesis and Biological Evaluation (7 papers) and Drug Transport and Resistance Mechanisms (3 papers). Laura Capolongo is often cited by papers focused on Cancer therapeutics and mechanisms (16 papers), Synthesis and Biological Evaluation (7 papers) and Drug Transport and Resistance Mechanisms (3 papers). Laura Capolongo collaborates with scholars based in Italy, United States and Germany. Laura Capolongo's co-authors include Maria Grandi, Nicola Mongelli, Cristina Geroni, Paolo Cozzi, Italo Beria, Enrico Pesenti, Maurizio D’Incalci, Gabriella Pezzoni, Dario Ballinari and Marina Caldarelli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Laura Capolongo

34 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Capolongo Italy 15 378 199 171 107 75 34 599
Matthew Labenski United States 12 405 1.1× 166 0.8× 200 1.2× 50 0.5× 161 2.1× 20 701
Indrasish Ray Chaudhuri United States 16 642 1.7× 244 1.2× 250 1.5× 72 0.7× 113 1.5× 26 1.1k
James M. Hamby United States 17 542 1.4× 121 0.6× 349 2.0× 53 0.5× 25 0.3× 32 828
Moorthy S. S. Palanki United States 18 441 1.2× 110 0.6× 297 1.7× 46 0.4× 30 0.4× 28 818
Catherine Sylvain France 6 680 1.8× 308 1.5× 221 1.3× 165 1.5× 45 0.6× 11 980
Stéphanie Blanchard Singapore 12 323 0.9× 166 0.8× 166 1.0× 76 0.7× 118 1.6× 29 548
Charles Watson Moore United States 8 205 0.5× 154 0.8× 166 1.0× 55 0.5× 41 0.5× 9 450
Yanong D. Wang United States 13 260 0.7× 107 0.5× 516 3.0× 118 1.1× 60 0.8× 17 753
Xavier Billot Canada 7 463 1.2× 152 0.8× 144 0.8× 57 0.5× 71 0.9× 10 769
Tadakazu Akiyama Japan 15 561 1.5× 303 1.5× 117 0.7× 116 1.1× 54 0.7× 17 832

Countries citing papers authored by Laura Capolongo

Since Specialization
Citations

This map shows the geographic impact of Laura Capolongo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Capolongo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Capolongo more than expected).

Fields of papers citing papers by Laura Capolongo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Capolongo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Capolongo. The network helps show where Laura Capolongo may publish in the future.

Co-authorship network of co-authors of Laura Capolongo

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Capolongo. A scholar is included among the top collaborators of Laura Capolongo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Capolongo. Laura Capolongo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Geroni, Cristina, Marina Ripamonti, Claudio Arrigoni, et al.. (2001). Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent.. PubMed. 61(5). 1983–90. 17 indexed citations
4.
Cozzi, Paolo, Italo Beria, Marina Caldarelli, et al.. (2000). Cytotoxic halogenoacrylic derivatives of distamycin A. Bioorganic & Medicinal Chemistry Letters. 10(11). 1269–1272. 28 indexed citations
5.
Cozzi, Paolo, Italo Beria, Marina Caldarelli, et al.. (2000). Phenyl sulfur mustard derivatives of distamycin A. Bioorganic & Medicinal Chemistry Letters. 10(15). 1653–1656. 13 indexed citations
6.
Sola, Francesco, et al.. (1999). The antitumor efficacy of cytotoxic drugs is potentiated by treatment with PNU 145156E, a growth-factor-complexing molecule. Cancer Chemotherapy and Pharmacology. 43(3). 241–246. 11 indexed citations
7.
Marchini, Sergio, Paolo Cozzi, Italo Beria, et al.. (1998). Sequence-specific DNA alkylation of novel tallimustine derivatives.. PubMed. 13(3). 193–205. 15 indexed citations
8.
BARALDI, P. G., Barbara Cacciari, A. Guiotto, et al.. (1997). Synthesis, solvolytic stability and cytotoxicity of a modified derivative of CPzI, a pyrazole analog of the alkylation subunit of the antitumor agent CC-1065: effect of the nitrogen substitution on the functional reactivity.. PubMed. 52(12). 717–23. 6 indexed citations
9.
Ghielmini, Michele, Giovanna Bosshard, Laura Capolongo, et al.. (1997). Estimation of the haematological toxicity of minor groove alkylators using tests on human cord blood cells. British Journal of Cancer. 75(6). 878–883. 30 indexed citations
10.
Ripamonti, Marina, et al.. (1996). Morpholinylanthracyclines: cytotoxicity and antitumor activity of differently modified derivatives. Investigational New Drugs. 14(2). 139–146. 7 indexed citations
11.
12.
Ciomei, Marina, et al.. (1995). Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine). British Journal of Cancer. 72(6). 1504–1508. 5 indexed citations
13.
Capolongo, Laura, Nadia Amboldi, Dario Ballinari, et al.. (1994). Reversal of Multidrug Resistance by New Dihydropyridines with Low Calcium Antagonist Activity. Acta Oncologica. 33(7). 787–791. 3 indexed citations
14.
Montecucco, Alessandra, et al.. (1994). Temperature influences both cytotoxicity and DNA nicking efficiency of the antitumor distamycin analogue FCE24517.. PubMed. 14(1A). 189–92. 1 indexed citations
15.
Mariani, Mariangela, Laura Capolongo, Alberto Bargiotti, et al.. (1994). Growth-inhibitory properties of novel anthracyclines in human leukemic cell lines expressing either Pgp-MDR or at-MDR. Investigational New Drugs. 12(2). 93–97. 14 indexed citations
16.
Capolongo, Laura, et al.. (1993). Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517). British Journal of Cancer. 68(5). 916–919. 9 indexed citations
17.
Pezzoni, Gabriella, Maria Grandi, Laura Capolongo, et al.. (1991). Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A. British Journal of Cancer. 64(6). 1047–1050. 60 indexed citations
18.
Cristalli, G., Sauro Vittori, Anna Maria Eleuteri, et al.. (1991). Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides: synthesis and biological activity. Journal of Medicinal Chemistry. 34(7). 2226–2230. 36 indexed citations
19.
Capolongo, Laura, G. Belvedere, & Maurizio D’Incalci. (1990). DNA damage and cytotoxicity of mitoxantrone and doxorubicin in doxorubicin-sensitive and-resistant human colon carcinoma cells. Cancer Chemotherapy and Pharmacology. 25(6). 430–434. 13 indexed citations
20.
Grandi, Maria, Gabriella Pezzoni, Dario Ballinari, et al.. (1990). Novel anthracycline analogs. Cancer Treatment Reviews. 17(2-3). 133–138. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew Labenski Breakdown of academic impact, for papers by Indrasish Ray Chaudhuri Breakdown of academic impact, for papers by James M. Hamby Breakdown of academic impact, for papers by Moorthy S. S. Palanki Breakdown of academic impact, for papers by Catherine Sylvain Breakdown of academic impact, for papers by Stéphanie Blanchard Breakdown of academic impact, for papers by Charles Watson Moore Breakdown of academic impact, for papers by Yanong D. Wang Breakdown of academic impact, for papers by Xavier Billot Breakdown of academic impact, for papers by Tadakazu Akiyama
Rankless by CCL
2026